Preoperative Blood Glucose Target
Target a blood glucose level of 100-180 mg/dL (5.6-10.0 mmol/L) within 4 hours of valve surgery, with a preoperative HbA1c goal of <8% (<64 mmol/L) whenever possible for elective procedures. 1
Key Perioperative Glucose Targets
The most recent American Diabetes Association guidelines (2024-2025) provide clear perioperative glycemic targets that apply to your patient undergoing valve surgery:
- Blood glucose range: 100-180 mg/dL (5.6-10.0 mmol/L) should be maintained within 4 hours of surgery 1
- Preoperative HbA1c: <8% (<64 mmol/L) is the target for elective surgeries whenever possible 1
Your patient's current HbA1c of 8% meets the threshold but represents suboptimal long-term glycemic control. While the surgery can proceed, recognize that this HbA1c level places them at the upper acceptable limit.
Evidence Supporting These Targets
Stricter targets are not recommended. Multiple guidelines consistently warn against perioperative glycemic goals tighter than 80-180 mg/dL (4.4-10.0 mmol/L), as they do not improve outcomes and significantly increase hypoglycemia risk 1. This is critical in valve surgery where hypoglycemia could be catastrophic.
The evidence base shows:
- Tight glycemic control (80-110 mg/dL) attempted in cardiac surgery increased mortality risk without benefit 2
- A meta-analysis confirmed that strict control was not associated with reduced hospital mortality but increased hypoglycemia 2
- Current consensus across multiple societies supports the 140-180 mg/dL range for most surgical patients 1, 3
Special Considerations for Valve Surgery
Valve surgery differs from CABG in important ways. Research specifically examining isolated cardiac valvular surgery found that postoperative glycemic variability was NOT associated with major adverse events, unlike in CABG patients 4. This suggests that while maintaining the 100-180 mg/dL target is appropriate, the tolerance for some variability may be greater than in coronary surgery.
However, preoperative HbA1c ≥7.0% has been associated with increased composite morbidity and mortality in cardiac surgery patients 5. Your patient's HbA1c of 8% warrants heightened vigilance for:
- Postoperative infections
- Wound complications
- Cardiovascular events
- Renal dysfunction 5
Chronic Liver Disease Impact
The presence of chronic liver disease adds complexity:
- Hepatic glucose production may be impaired, increasing hypoglycemia risk
- Insulin clearance may be altered
- Monitor glucose more frequently (every 2-4 hours minimum while NPO) 1
- Consider reducing basal insulin by 25% the evening before surgery to minimize hypoglycemia risk while maintaining target range 1
Practical Perioperative Management
Day of surgery medication adjustments:
- Hold metformin on the day of surgery 1
- Discontinue SGLT2 inhibitors 3-4 days before surgery 1
- Hold other oral glucose-lowering agents the morning of surgery 1
- Give 75-80% of long-acting basal insulin dose or one-half of NPH dose 1
Intraoperative and immediate postoperative period:
- Monitor blood glucose at least every 2-4 hours while NPO 1
- Use short- or rapid-acting insulin for corrections as needed 1
- Do NOT use CGM alone for glucose monitoring during surgery 1
- Implement basal-bolus insulin regimen (not correction-only sliding scale) postoperatively for superior glycemic outcomes and lower complication rates 1
Common Pitfalls to Avoid
Do not attempt euglycemia. The temptation to achieve "normal" glucose levels (80-110 mg/dL) perioperatively is dangerous and increases mortality 2, 3. The 100-180 mg/dL target represents the optimal balance between hyperglycemia-related complications and hypoglycemia risk.
Do not rely on correction insulin alone. Reactive sliding-scale insulin without basal coverage is associated with worse glycemic outcomes and higher perioperative complication rates compared to basal-bolus regimens 1.
Do not ignore the HbA1c. While your patient's HbA1c of 8% meets the cutoff for proceeding with surgery, it signals increased risk. Some institutions have developed preoperative optimization programs to lower HbA1c before elective surgery 1. If the valve surgery is truly elective and can be safely delayed, consider optimizing glycemic control first, though this must be balanced against cardiac risk.